Laman UtamaBRNS • NASDAQ
add
Barinthus Biotherapeutics PLC - ADR
$1.11
Selepas Waktu Dagangan:(0.41%)+0.0045
$1.11
Tutup: 18 Sep, 5:27:05 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$1.07
Julat hari
$1.08 - $1.11
Julat tahun
$0.64 - $2.92
Permodalan pasaran
44.99J USD
Bilangan Purata
40.80K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Times Colonist
13 jam lalu
S&P/TSX composite rises amid 'bullish' sentiment from lower borrowing costs
0.45%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | — | — |
Perbelanjaan pengendalian | 21.98J | 28.65% |
Pendapatan bersih | -21.12J | -24.77% |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | -0.52 | -20.93% |
EBITDA | -20.78J | -22.78% |
Kadar cukai berkesan | 0.12% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 86.26J | -26.76% |
Jumlah aset | 129.56J | -30.62% |
Jumlah liabiliti | 27.08J | -9.61% |
Jumlah ekuiti | 102.48J | — |
Syer tertunggak | 40.72J | — |
Harga kepada buku | 0.42 | — |
Pulangan pada aset | -40.47% | — |
Pulangan pada modal | -45.42% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -21.12J | -24.77% |
Tunai daripada operasi | -18.11J | -50.83% |
Tunai daripada pelaburan | -32.00K | 83.33% |
Tunai daripada pembiayaan | 0.00 | -100.00% |
Perubahan bersih dalam tunai | -12.80J | -4.90% |
Aliran tunai bebas | -14.78J | -119.52% |
Perihal
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
Diasaskan
2016
Tapak web
Pekerja
105
